CD19 and diffuse large B-cell lymphoma: Moreover, patients with diffuse large B-cell lymphoma were recruited in a clinical trial in which the treatment with CD19 CAR-T expressing IL-7 and CCL-19 has been combined with PD-1 monoclonal antibody.